Nicolas Wolikow Founder of Cure51 Backed byLife Extension VenturesInaki Berenguer LinkedIn SourcesParis-based Cure51 raises €15 million to develop first-in-class treatments from exceptional cancer survivors — 2024-03 Browse all founders · Browse investors
